BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36458463)

  • 21. Tuning the degradation rate of calcium phosphate cements by incorporating mixtures of polylactic-co-glycolic acid microspheres and glucono-delta-lactone microparticles.
    Sariibrahimoglu K; An J; van Oirschot BA; Nijhuis AW; Eman RM; Alblas J; Wolke JG; van den Beucken JJ; Leeuwenburgh SC; Jansen JA
    Tissue Eng Part A; 2014 Nov; 20(21-22):2870-82. PubMed ID: 24819744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term variations in mechanical properties and in vivo degradability of CPC/PLGA composite.
    Dagang G; Haoliang S; Kewei X; Yong H
    J Biomed Mater Res B Appl Biomater; 2007 Aug; 82(2):533-44. PubMed ID: 17318820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium phosphate/poly(D,L-lactic-co-glycolic acid) composite bone substitute materials: evaluation of temporal degradation and bone ingrowth in a rat critical-sized cranial defect.
    van de Watering FCJ; van den Beucken JJJP; Walboomers XF; Jansen JA
    Clin Oral Implants Res; 2012 Feb; 23(2):151-159. PubMed ID: 21631594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porous calcium phosphate-poly (lactic-co-glycolic) acid composite bone cement: A viable tunable drug delivery system.
    Roy A; Jhunjhunwala S; Bayer E; Fedorchak M; Little SR; Kumta PN
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():92-101. PubMed ID: 26652353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The GDF5 mutant BB-1 enhances the bone formation induced by an injectable, poly(l-lactide-co-glycolide) acid (PLGA) fiber-reinforced, brushite-forming cement in a sheep defect model of lumbar osteopenia.
    Gunnella F; Kunisch E; Maenz S; Horbert V; Xin L; Mika J; Borowski J; Bischoff S; Schubert H; Sachse A; Illerhaus B; Günster J; Bossert J; Jandt KD; Plöger F; Kinne RW; Brinkmann O; Bungartz M
    Spine J; 2018 Feb; 18(2):357-369. PubMed ID: 29031993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro degradation, biocompatibility, and in vivo osteogenesis of poly(lactic-co-glycolic acid)/calcium phosphate cement scaffold with unidirectional lamellar pore structure.
    He F; Ye J
    J Biomed Mater Res A; 2012 Dec; 100(12):3239-50. PubMed ID: 22733543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone response to fast-degrading, injectable calcium phosphate cements containing PLGA microparticles.
    Félix Lanao RP; Leeuwenburgh SC; Wolke JG; Jansen JA
    Biomaterials; 2011 Dec; 32(34):8839-47. PubMed ID: 21871661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres.
    Félix Lanao RP; Leeuwenburgh SC; Wolke JG; Jansen JA
    Acta Biomater; 2011 Sep; 7(9):3459-68. PubMed ID: 21689794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mini-Pig Mandibular Defect Model for Evaluation of Craniomaxillofacial Bone Regeneration.
    van Oirschot BAJA; Geven EJW; Mikos AG; van den Beucken JJJP; Jansen JA
    Tissue Eng Part C Methods; 2022 May; 28(5):193-201. PubMed ID: 35262400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and histomorphometric evaluation of a novel fluvastatin-containing poly(lactic-co-glycolic acid) membrane for guided bone regeneration.
    Zhang H; Moriyama Y; Ayukawa Y; Rakhmatia YD; Tomita Y; Yasunami N; Koyano K
    Odontology; 2019 Jan; 107(1):37-45. PubMed ID: 30022371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporation of bioactive glass in calcium phosphate cement: material characterization and in vitro degradation.
    Renno AC; Nejadnik MR; van de Watering FC; Crovace MC; Zanotto ED; Hoefnagels JP; Wolke JG; Jansen JA; van den Beucken JJ
    J Biomed Mater Res A; 2013 Aug; 101(8):2365-73. PubMed ID: 23364896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and characterization of a calcium phosphate bone cement with quercetin-containing PEEK/PLGA microparticles.
    Kiakojoori K; Najafi F; Torshabi M; Kazemi S; Rabiee SM; Nojehdehian H
    Biomed Mater; 2022 Nov; 18(1):. PubMed ID: 36327455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of the biomaterials 3wt%-nanostrontium-hydroxyapatite-enhanced calcium phosphate cement (nanoSr-CPC) and nanoSr-CPC-incorporated simvastatin-loaded poly(lactic-co-glycolic-acid) microspheres in osteogenesis improvement: An explorative multi-phase experimental in vitro/vivo study.
    Masaeli R; Jafarzadeh Kashi TS; Dinarvand R; Rakhshan V; Shahoon H; Hooshmand B; Mashhadi Abbas F; Raz M; Rajabnejad A; Eslami H; Khoshroo K; Tahriri M; Tayebi L
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():171-83. PubMed ID: 27612702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injectable calcium phosphate cement with PLGA, gelatin and PTMC microspheres in a rabbit femoral defect.
    Liao H; Walboomers XF; Habraken WJ; Zhang Z; Li Y; Grijpma DW; Mikos AG; Wolke JG; Jansen JA
    Acta Biomater; 2011 Apr; 7(4):1752-9. PubMed ID: 21185953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal porogen platforms for calcium phosphate cement degradation.
    Lodoso-Torrecilla I; Grosfeld EC; Marra A; Smith BT; Mikos AG; Ulrich DJ; Jansen JA; van den Beucken JJ
    J Biomed Mater Res A; 2019 Aug; 107(8):1713-1722. PubMed ID: 30920119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An experimental study on a slow-release complex with rifampicin-polylactic-co-glycolic acid-calcium 
phosphate cement].
    Wu J; Ding Z; Lei Q; Li M; Liang Y; Lu T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):946-54. PubMed ID: 27640793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of adding resorbable chitosan microspheres to calcium phosphate cements for bone regeneration.
    Meng D; Dong L; Wen Y; Xie Q
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():266-72. PubMed ID: 25492197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of cell response of the poly(lactic-co-glycolic acid)/calcium phosphate cement composite scaffold with unidirectional pore structure by the surface immobilization of collagen via plasma treatment.
    He F; Li J; Ye J
    Colloids Surf B Biointerfaces; 2013 Mar; 103():209-16. PubMed ID: 23201739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Size matters: effects of PLGA-microsphere size in injectable CPC/PLGA on bone formation.
    Liao H; Félix Lanao RP; van den Beucken JJ; Zhou N; Both SK; Wolke JG; Jansen JA
    J Tissue Eng Regen Med; 2016 Aug; 10(8):669-78. PubMed ID: 24170734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced bone formation in sheep vertebral bodies after minimally invasive treatment with a novel, PLGA fiber-reinforced brushite cement.
    Maenz S; Brinkmann O; Kunisch E; Horbert V; Gunnella F; Bischoff S; Schubert H; Sachse A; Xin L; Günster J; Illerhaus B; Jandt KD; Bossert J; Kinne RW; Bungartz M
    Spine J; 2017 May; 17(5):709-719. PubMed ID: 27871820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.